CStone Pharmaceuticals (CSPHF) Discusses CS2009 Data Interpretation and Future Clinical Development Strategy Transcript

CStone Pharmaceuticals ( OTCPK:CSPHF) Discusses CS2009 Data Interpretation and Future Clinical Development Strategy October 20, 2025 9:00 AM EDT ...

Daiichi Sankyo Company, Limited (DSNKY) Discusses ESMO 2025 Highlights With Focus on Key Breast Cancer Trial Data and Regulatory Submissions Transcript

Daiichi Sankyo Company, Limited ( OTCPK:DSNKY) Discusses ESMO 2025 Highlights With Focus on Key Breast Cancer Trial Data and Regulatory Submissions October 21, 2025 8:00 AM EDT ...

Allied Critical Metals Drills 10.0 Metres of 1.11% Tungsten (WO3) at Borralha

Substantial Assays Strengthen Shallow Central-South Mineralization and Support Robust Outlook for Upcoming Preliminary ...
Le Lézard

Stellar Cyber Named Representative Vendor in Gartner® 2025 Hype Cycletm for Security Operations

Stellar Cyber, the cybersecurity illumination company, today announced it has been recognized as a Representative Vendor in the 2025 Gartner® Hype Cycletm for Security Operations under the Extended ...

Non-Alcoholic Steatohepatitis Pipeline 2025: Therapies, MOA Insights, and Key Clinical Trial Updates by DelveInsight | Viking Therapeutics, Seal Rock Therapeutics, …

Non-Alcoholic Steatohepatitis Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present ...